Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2020-05-26

FDA Approved: ZOSYN IN GALAXY CONTAINERS — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)

View source ↗

Summary

FDA approved a supplemental application for ZOSYN in Galaxy containers, a packaging/labeling change for the piperacillin/tazobactam product. The change does not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zosyn (Piperacillin/tazobactam)

Snippet

SUPPL AP for ZOSYN IN GALAXY CONTAINERS (TAZOBACTAM SODIUM AND PIPERACILLIN SODIUM)